Menu
Cardiology / Cardiovascular

HFmrEF

ICD-10 Code
I50.2

Comprehensive clinical criteria for HFmrEF

Clinical Presentation & Protocol

Patient Usually Complains Of

Patient presents with symptoms of heart failure (NYHA class [I-IV]), including exertional dyspnea, orthopnea, and paroxysmal nocturnal dyspnea. Recent echocardiogram confirms LVEF 41-49%. History significant for [HTN/CAD/DM/Valvular disease]. Current functional status is [stable/deteriorating] with [no/documented] recent hospitalizations for decompensated HF.

Clinical Examination Findings

Vitals: BP [X/Y], HR [Z] bpm, SpO2 [W]%. General: Patient in [no/mild/moderate] distress. CV: Regular rate and rhythm, S1/S2 present, [no/S3/S4] gallop, [no/grade X/VI] systolic murmur. Lungs: [Clear to auscultation/bilateral crackles at bases]. Extremities: [No/trace/1+/2+] pitting edema, peripheral pulses [intact/diminished]. JVP [normal/elevated] at [X] cm H2O.

Treatment Protocol

Initiate/Optimize GDMT for HFmrEF: 1. Beta-blocker ([Drug/Dose]), 2. ACEi/ARB/ARNI ([Drug/Dose]), 3. MRA ([Drug/Dose]), 4. SGLT2 inhibitor ([Drug/Dose]). Diuretic therapy ([Drug/Dose]) titrated to euvolemia. Monitor electrolytes, renal function, and BP. Follow-up in [X] weeks for clinical reassessment.

Detailed clinical guide coming soon.